Filtered By:
Countries: Canada Health
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 670 results found since Jan 2013.
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
The Global Initiative for Asthma recommends the use of as-needed low-dose inhaled corticosteroid (ICS)-formoterol as a preferred controller therapy for patients with mild asthma. These recommendations were bas...
Source: Allergy, Asthma and Clinical Immunology - October 12, 2021 Category: Allergy & Immunology Authors: Mohsen Sadatsafavi, J. Mark FitzGerald, Paul M. O ’Byrne, Mena Soliman, Niroshan Sriskandarajah, Colin Vicente and Sarowar Muhammad Golam Tags: Research Source Type: research
New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque psoriasis (P...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Use of electronic medical records to describe the prevalence of allergic diseases in Canada
Leveraging the data management resources of the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) is a viable approach for describing the prevalence of allergic disease documented in primary care se...
Source: Allergy, Asthma and Clinical Immunology - August 18, 2021 Category: Allergy & Immunology Authors: Alexander G. Singer, Leanne Kosowan, Nerissa Nankissoor, Ryan Phung, Jennifer L. P. Protudjer and Elissa M. Abrams Tags: Short Report Source Type: research
Canadian food ladders for dietary advancement in children with IgE-mediated allergy to milk and/or egg
Food ladders are clinical tools already widely used in Europe for food reintroduction in milk- and egg-allergic children. Previously developed milk and egg ladders have limited applicability to Canadian childr...
Source: Allergy, Asthma and Clinical Immunology - August 5, 2021 Category: Allergy & Immunology Authors: Alanna Chomyn, Edmond S. Chan, Joanne Yeung, Timothy K. Vander Leek, Brock A. Williams, Lianne Soller, Elissa M. Abrams, Raymond Mak and Tiffany Wong Tags: Letter to the Editor Source Type: research
Demographic and clinical characteristics of patients with hereditary angioedema in Canada
CONCLUSION: Canadian patients with HAE share common clinical characteristics with HAE patients in other countries. They showed a delay in HAE diagnosis and a high burden of disease as indicated by the high frequency of attacks in the preceding 6 months. This study provides a better understanding of the demographic and clinical characteristics Canadian patients with HAE.PMID:34298173 | DOI:10.1016/j.anai.2021.07.015
Source: Annals of Allergy, Asthma and Immunology - July 23, 2021 Category: Allergy & Immunology Authors: Erika Yue Lee Jane Hsieh Teresa Caballero Christine McCusker Amin Kanani Gina Lacuesta Rozita Borici-Mazi Susan Waserman Stephen Betschel Source Type: research
Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada
Hereditary angioedema (HAE) is a rare autosomal dominant disease resulting in recurring episodes of swelling, leading to considerable patient morbidity and mortality. Lanadelumab is a plasma kallikrein inhibit...
Source: Allergy, Asthma and Clinical Immunology - July 23, 2021 Category: Allergy & Immunology Authors: Aled Iaboni, Amin Kanani, Gina Lacuesta, Christine Song, Manstein Kan and Stephen D. Betschel Tags: Letter to the Editor Source Type: research
Demographic and clinical characteristics of patients with hereditary angioedema in Canada
Data on the clinical and demographic features of Canadian patients with hereditary angioedema (HAE) is lacking.
Source: Annals of Allergy, Asthma and Immunology - July 19, 2021 Category: Allergy & Immunology Authors: Erika Yue Lee, Jane Hsieh, Teresa Caballero, Christine McCusker, Amin Kanani, Gina Lacuesta, Rozita Borici-Mazi, Susan Waserman, Stephen Betschel Tags: Original Article Source Type: research
Demographic characteristics associated with food allergy in a Nationwide Canadian Study
We conducted a nationwide Canadian telephone survey on food allergy prevalence between February 2016 and January 2017, targeting vulnerable populations (New, Indigenous, and lower-income Canadians).
Source: Allergy, Asthma and Clinical Immunology - July 17, 2021 Category: Allergy & Immunology Authors: Ann E. Clarke, Susan J. Elliott, Yvan St. Pierre, Lianne Soller, Sebastien La Vieille and Moshe Ben-Shoshan Tags: Letter to the Editor Source Type: research
Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19
Ann Allergy Asthma Immunol. 2021 Jul 11:S1081-1206(21)00495-6. doi: 10.1016/j.anai.2021.07.006. Online ahead of print.NO ABSTRACTPMID:34260902 | DOI:10.1016/j.anai.2021.07.006
Source: Annals of Allergy, Asthma and Immunology - July 14, 2021 Category: Allergy & Immunology Authors: Sofianne Gabrielli Jennifer Lp Protudjer Gregory Gooding Jennifer Gerdts Moshe Ben-Shoshan Source Type: research
Allergic reactions to emerging food allergens in Canadian children
This study describes which non-priority (emerging) food allergens were most commonly reported by Canadian parents and cat...
Source: Allergy, Asthma and Clinical Immunology - July 13, 2021 Category: Allergy & Immunology Authors: Lianne Soller, Sebastien La Vieille, Scott B. Cameron, Raymond Mak, Victoria E. Cook, Jennifer Gerdts and Edmond S. Chan Tags: Letter to the Editor Source Type: research
Anaphylaxis-related knowledge and concerns in Canadian families during the coronavirus disease 2019 pandemic
Anaphylaxis is a life-threatening condition defined as the involvement of 2 or more systems after exposure to a possible allergen or hypotension after exposure to a known allergen.1-3 The first-line treatment for anaphylaxis is prompt administration of an epinephrine autoinjector (EAI).4 Guidelines advise that after epinephrine administration, patients should arrive to the emergency department (ED) for assessment and observation.2,3 A recent editorial recommends that cases in which symptoms resolve after EAI administration, patients could manage anaphylaxis at home and notify their physician on a nonurgent basis.
Source: Annals of Allergy, Asthma and Immunology - July 11, 2021 Category: Allergy & Immunology Authors: Sofianne Gabrielli, Jennifer L.P. Protudjer, Gregory Gooding, Jennifer Gerdts, Moshe Ben-Shoshan Tags: Letters Source Type: research
Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19
Epinephrine autoinjector
Source: Annals of Allergy, Asthma and Immunology - July 11, 2021 Category: Allergy & Immunology Authors: Sofianne Gabrielli, Jennifer LP Protudjer, Gregory Gooding, Jennifer Gerdts, Moshe Ben-Shoshan Source Type: research
